The complex of PP1 with the leucine-rich repeat protein SHOC2 promotes tumor growth in a subset of KRAS-mutant NSCLC cell lines by dephosphorylating a critical inhibitory site on RAF kinases, resulting in RAF-ERK pathway activation. Here, NYX is linked to non-small cell lung carcinoma.